期刊文献+

非甾体类环氧化酶-2选择性抑制剂与抗肿瘤作用机制探讨 被引量:4

原文传递
导出
摘要 目的:分析综述非甾体类与肿瘤关系,探讨非甾体类环氧化酶-2(COX-2)选择性抑制剂的抗肿瘤作用的机制。方法:以近几年国内外在该领域有代表性的文献为根据,进一步进行归纳,总结。结论:非甾体类COX-2选择性抑制剂对预防肿瘤发生及抑制肿瘤生长和转移方面在临床上取得一定的效果,但在临床上要有更广泛的应用还有许多问题尚待解决,其全面作用机制也有待进一步阐明。
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2010年第22期1936-1937,1942,共3页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献5

二级参考文献60

  • 1刘宁波,彭韬,沈波,冷静.选择性抑制剂celecoxib诱导肝癌细胞凋亡及其相关分子机制的实验研究[J].南京医科大学学报(自然科学版),2004,24(4):321-324. 被引量:11
  • 2朱宏,施瑞华,张国新,凌亭生,郝波.环氧合酶-2、血管内皮生长因子和微血管密度与食管鳞癌病理特征的关系[J].南京医科大学学报(自然科学版),2005,25(2):84-86. 被引量:11
  • 3JunYu,Bao-DongTang,WaiK.Leung,Ka-FaiTo,AlfaH.C.Bai,Zhi-RongZeng,Po-KiMa,MinnieY.Y.Go,Pin-JinHu,JosephJ.Y.Sung.Different cell kinetic changes in rat stomach cancer after treatment with celecoxib or indomethacin: Implications on chemoprevention[J].World Journal of Gastroenterology,2005,11(1):41-45. 被引量:38
  • 4Saito M, Hamasaki M, Shibuya M. Induction of tube formation by angiopoietin-1 in endothelial cell/fibroblast co-culture is dependent on endogenous VEGF. Cancer Sci 2003; 94: 782-790
  • 5Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999; 286: 2511-2514
  • 6Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6: 460-463
  • 7Ahmad SA, Liu W, Jung YD, Fan F, Reinmuth N, Bucana CD, Ellis LM. Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcino-ma. A possible mechanism for the initiation of angiogenesis. Cancer 2001; 92: 1138-1143
  • 8Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wieg-and SJ. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284: 1994-1998
  • 9Holash J, Wiegand SJ, Yancopoulos GD. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angio-poietins and VEGF. Oncogene 1999; 18: 5356-5362
  • 10Lobov IB, Brooks PC, Lang RA. Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 2002; 99: 11205-11210

共引文献32

同被引文献70

  • 1Paice JA, Ferrell B, The Management of Cancer Pain. CA Cancer J Clin, 2011, 61 : 157 - 182.
  • 2Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res, 2006, 12 : 6243s - 6249s.
  • 3Delaney A, Fleetwood-Walker SM, Colvin LA, et al. Translational medicine: cancer pain mechanisms and management. Br J Anaesth, 2008, 101 : 87-94.
  • 4Suva L J, Washam C, Richard W, et al. Bone meta- stasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol, 2011, 7 : 208 - 218.
  • 5Luger NM, Mach DB, Sevcik MA, et al. Bone canc- er pain: from model to mechanism to therapy J Pa- in symptom manage, 2005, 29 : S32 - S46.
  • 6Rainsford KD. Anti-inflammatory drugs in the 21 st century. Subcell Biochem, 2007, 42 : 3 - 27.
  • 7Saito O, Aoe T, Yamamoto T. Analgesic effects of nonsteroidal antiinflammatory drugs, acetaminoph- en, and morphine in a mouse model of bone cancer pain. J Anesth, 2005, 19 : 218 - 224.
  • 8McNicol E, Strassels SA, Goudas L, et al. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev, 2005, 1 : 5180.
  • 9King T, Vardanyan A, Majuta L, et al. Morphine treatment accelerates sarcoma-induc-ed bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer. Pain, 2007, 132 : 154 - 68.
  • 10Costa L, Lipton A, Coleman RE. Role of Bisphosp- honates for the Mangement of Skeletal Complica- tions and Bone Pain from Skeletal metastases. Suppot Cancer Ther, 2006, 3 : 143 - 153.

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部